BioCentury
ARTICLE | Financial News

Versicor sells shoe

September 7, 2000 7:00 AM UTC

VERS, a developer of anti-bacterial and anti-fungal treatments, raised $7.6 million through the sale of 690,000 shares at $11 authorized to cover overallotments in its August IPO. The sale brings to $...